heidi muller

A passion for people, patients and partnerships

[Lakefront Biotherapeutics @LakefrontBio]

We attended & supported the @eupatientsforum, focusing on the further digital transformation of healthcare. Anca Toma, Executive Director of EPF, voiced key elements for sustainable digitalization: trust, consent, inclusiveness, collaboration & dialogue. #EPFcongress2022

[heidi muller @heidi_hmuller]

Exciting times! #galapagos #PatientEngagement

[Lakefront Biotherapeutics @LakefrontBio]

The launch of our #PatientPartnership Charter is a crucial and tangible step forward in our journey to build deeper, long-term partnerships with the patient community. Read more in our Annual Report Magazine: https://t.co/PSz29PSyyv
#PioneeringForPatients

[Onno van de Stolpe @OvandeStolpe]

Proud and happy that Paul Stoffels will take over the CEO role at Galapagos. Paul is one of the world’s most successful leaders in the industry and also a co-founder of the company. This will be the turning point - welcome Paul!

[heidi muller @heidi_hmuller]

The importance of caregivers who make the difference for those living a disease

[Lakefront Biotherapeutics @LakefrontBio]

“We are not just sitting here to let it take over. We’re fighting." For patients, caregivers are as essential as their physician. We asked Maxine, Ron’s wife & caregiver, how she sees a caregivers’ role when it comes to #ClinicalTrials. 👇 https://t.co/2NUsejvtYz

[Lakefront Biotherapeutics @LakefrontBio]

Patients are our North Star. Their needs guide everything we do. We are committed to working for patients, with patients.
📽️ Watch the video: https://t.co/xUndEnle6e
ℹ️ Discover more: https://t.co/agrU90TWMD
#ARmagazine #PioneeringForPatients

[Lakefront Biotherapeutics @LakefrontBio]

As #PFSUMMIT21 draws to an end, we’re delighted to have been part of this journey. At Galapagos, we believe that through partnership we can work together to improve PF care. Steve Jones @ActionPFsteve of @EU_IPFF agrees with this approach. Thank you for an inspiring summit. 🤝

[Made WITH Patients @PFMDwithPatient]

Today at #PEOF, we'll cocreate the process of transforming @imi_paradigm "Patient Engagement Metrics Framework" into a customised tool for anyone working on a #patientengagement initiative. Check out session pre-reads & join us at 16:30 CET.
➡️ https://t.co/g8SlzYjnQU

[heidi muller @heidi_hmuller]

@Chi_Chicilee Great session indeed!

[Lakefront Biotherapeutics @LakefrontBio]

It’s @RareDiseaseDay! We are proud to join @EURORDIS in supporting the courage, strength and resilience of the 300 million people living with #RareDiseases.

Watch what this day means to Ron, who lives with a rare & progressive disease #IPF

https://t.co/Q0JvBPte50

[Lakefront Biotherapeutics @LakefrontBio]

Our patient advocacy lead @MarinaSardone had a great discussion with @EURORDIS on why initiatives like @rarediseaseday are so important for the #RareDiseases patient community.

Read more about it https://t.co/osrzS4eOOF

#RareDiseaseDay #PioneeringforPatients

[Lakefront Biotherapeutics @LakefrontBio]

It’s @rarediseaseday week and we are looking forward to sharing an inspiring story of strength and resilience to support voices of the #RareDiseases patient community. Watch this space! #MyPFStory

[Lakefront Biotherapeutics @LakefrontBio]

Are you active in research in the field of #inflammation? Our Search & Evaluation team is looking for in-depth collaborations with academic groups & start-ups. 👉 https://t.co/wXcLEoMmxb
#PioneeringForPatients #Collaboration #Biotech #Academia

[heidi muller @heidi_hmuller]

Great achievement: congrats to all contributors!

[Made WITH Patients @PFMDwithPatient]

.@imi_paradigm project comes to an end, another milestone in #patientengagement achieved ✅ @PFMDwithPatient congratulates all partners & supporters with a commitment to continue the legacy towards #patientinvolvement with #PEOF 2021 & continuing to advance #PE tools. Stay tuned!

[heidi muller @heidi_hmuller]

How COVID-19 has Permanently Changed Patient Behavior | Accenture​ https://t.co/tDAYSAZ9M7

[European Patients' Forum @eupatientsforum]

"Patients’ emotions matter in the regulation of medicines" - take a look at recent opinion on considering the emotional (not only physical) impact of patients involved in regulatory affairs by EPF President Marco Greco and Natalie Bere of @EMA_News here: https://t.co/wMfrsFbmKJ

[Lakefront Biotherapeutics @LakefrontBio]

Research has shown that #RheumatoidArthritis can affect all aspects of a person’s life, including social relationships, family life, and psychological well-being.

[Lakefront Biotherapeutics @LakefrontBio]

Today, on #WorldArthritisDay, we recognize how crucial the patient voice is, and we commit to prioritizing what is important for people living with Rheumatoid Arthritis in their treatment and care. #PioneeringForPatients https://t.co/YWMwIfc2Zn

[Lakefront Biotherapeutics @LakefrontBio]

Someday just became today. Four simple words describe a complex yet exciting journey spanning over two decades. From a biotech start-up to an international biotech company, bringing innovative medicines to patients. #PioneeringForPatients

[Lakefront Biotherapeutics @LakefrontBio]

“There is an alarming variation in access to IPF care and management across Europe; urgent action is required”. Dr Francesco Bonella (@fratommy75), MD, Associate Professor at the Center for interstitial and rare lung diseases at @unidue. #ERSCongress #IdiopathicPulmonaryFibrosis

[Lakefront Biotherapeutics @LakefrontBio]

We are looking forward to the results of the EU-IPFF #BenchMarkingReport: IPF Care Across Europe. Knock it out of the park tomorrow, @EU_IPFF, @fratommy75 & @jmifourrier! 👍💪 #PioneeringForPatients #ERSCongress #IPF